New insights into atypical Alzheimer's disease in the era of biomarkers

Article reviews clinical features of atypical Alzheimer's disease and common scenarios regarding delayed diagnosis; advances in biomarkers and quantitative neuropathology; key aspects of individualised treatment approaches; and unique opportunities provided by atypical phenotypes

The Lancet Neurology